William H. Cook

William H. Cook

Auto-generated profile, based on publicly available information

William H. Cook

Division of Neurosurgery, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in Indian Journal Of Ophthalmology
Verified
Journal Article
Open access
PDF file
Stuti MisraStuti Misra
Stuti Misra
WCWilliam H Cook
William H Cook
JMJames McKelvie
James McKelvie
HWHenry B Wallace
Henry B Wallace
Purpose: To evaluate the agreement of selected higher order aberration measurements between aberrometers based on three different wavefront technologies. Methods: Twenty-three eyes of 23 participants were compared between Zywave, OPD-Scan III, and iDesign aberrometers, for total ocular aberrations. Participants were between 19 and 69 years of age, and exclusion criteria were previous ocular surgery or trauma, contact lens wear within the preceding 2 weeks, and ocular or systemic disease. Corneal aberrations were compared between the OPD-Scan III and GALILEI™ G2 aberrometers. Zernike coefficients of vertical and oblique trefoil, vertical and horizontal coma, and spherical aberration were analyzed in R software. Results: In all, 276 scans were captured in total, with a male-to-female ratio of 11:12. Total ocular vertical coma [mean difference (MD) = 0.026 μm, P < 0.005], vertical trefoil (MD = 0.033 μm, P < 0.05), and spherical aberration (MD = 0.022 μm, P < 0.05) differed significantly between the iDesign and OPD-Scan III. Differences in total vertical (MD = 0.072 μm, P < 0.05) and oblique trefoil (MD = 0.058 μm, P < 0.05) were demonstrated between the Zywave and OPD-Scan III, and spherical aberration (MD = 0.030 μm, P < 0.005) between iDesign and Zywave. iDesign corneal horizontal coma (MD = 0.025 μm, P < 0.05) and spherical aberration (MD = 0.043 μm, P < 0.005) measurements were significantly different between the GALILEI™ G2 and the OPD-Scan III. Conclusion: Zywave, iDesign, and OPD-Scan III, and GALILEITM G2 and OPD-Scan III may be used interchangeably for their total ocular and corneal wavefront functions, respectively; however, care must be taken if using these devices for guiding ablation or monitoring corneal disease.

17 December 2024 in Acta Neurochirurgica
Verified
Journal Article
Open access
PDF file
SASiraj Y. Abualnaja
Siraj Y. Abualnaja
JMJames S. Morris
James S. Morris
HRHamza Rashid
Hamza Rashid
WCWilliam H. Cook
William H. Cook
AHAdel Helmy
Adel Helmy
Purpose: Meningiomas are the most common primary brain tumour and account for over one-third of cases. Traditionally, estimations of morbidity and mortality following surgical resection have depended on subjective assessments of various factors, including tumour volume, location, WHO grade, extent of resection (Simpson grade) and pre-existing co-morbidities, an approach fraught with subjective variability. This systematic review and meta-analysis seeks to evaluate the efficacy with which machine learning (ML) algorithms predict post-operative outcomes in meningioma patients. Methods: A literature search was conducted in December 2023 by two independent reviewers through PubMed, DARE, Cochrane Library and SCOPUS electronic databases. Random-effects meta-analysis was conducted. Results: Systematic searches yielded 32 studies, comprising 142,459 patients and 139,043 meningiomas. Random-effects meta-analysis sought to generate restricted maximum-likelihood estimates for the accuracy of alternate ML algorithms in predicting several postoperative outcomes. ML models incorporating both clinical and radiomic data significantly outperformed models utilizing either data type alone as well as traditional methods. Pooled estimates for the AUCs achieved by different ML algorithms ranged from 0.74–0.81 in the prediction of overall survival and progression-/recurrence-free survival, with ensemble classifiers demonstrating particular promise for future clinical application. Additionally, current ML models may exhibit a bias in predictive accuracy towards female patients, presumably due to the higher prevalence of meningiomas in females. Conclusion: This review underscores the potential of ML to improve the accuracy of prognoses for meningioma patients and provides insight into which model classes offer the greatest potential for predicting survival outcomes. However, future research will have to directly compare standardized ML methodologies to traditional approaches in large-scale, prospective studies, before their clinical utility can be confidently validated.

31 January 2025 in World Neurosurgery
Verified
Journal Article
Open access
CGConor Gillespie
Conor Gillespie
AMAnca Mihaela-Vasilica
Anca Mihaela-Vasilica
JDJasneet Dhaliwal
Jasneet Dhaliwal
Keng Siang LeeKeng Siang Lee
Keng Siang Lee
AHAlex E. Henney
Alex E. Henney
SMSamir Matloob
Samir Matloob
Hyponatremia after aneurysmal subarachnoid hemorrhage (aSAH) is common; however, the incidence, and association with vasospasm, morbidity, and mortality, has yet to be defined. We aimed to identify incidence of hyponatremia after aSAH, and quantify its association with measurable outcomes. A Preferred Reporting Items for Systematic Reviews and Meta-Analyses-compliant systematic review and meta-analysis was conducted (international prospective register of systematic reviews ID CRD42022363472). Articles published in MEDLINE, Embase, and Cochrane Library between January 1990 and January 2024 were included. Hyponatremia definitions, incidence during admission, and association among vasospasm, length of hospital stay, and poor outcome (Glasgow Outcome Scale 3 or less) were identified. Pooled incidence rates and binary and continuous outcomes were calculated using random effects meta-analysis models. In total, 52 studies (10,512 patients) were included. Most studies included patients admitted to tertiary neuroscience centers (61.5%, N = 32), or critical care units (23.1%, N = 11). Sodium of less than 135 mmol/L was the most commonly used hyponatremia definition (84.6%, N = 44). The pooled incidence of hyponatremia was 37.0% (95% confidence interval [CI]: 31.7%-42.4%). Hyponatremia increased the risk of vasospasm (15 studies; odds ratio: 2.93; 95% CI: 1.77-4.84), and length of hospital stay (3 studies, 16.4 days vs. 8.0 days, mean difference 8.5 [95% CI: 4.6-12.4]), but was not associated with poor outcome (10 studies; odds ratio 1.15; 95% CI 0.44-3.02). These findings remained when carrying out sensitivity analysis for different hyponatremia and outcome definitions, bias, and aSAH populations. Hyponatremia is common in aSAH, may increase the likelihood of vasospasm, but in isolation does not appear to affect overall outcomes. Managing hyponatremia effectively should be a priority for treating clinicians.

29 July 2025 in Epilepsia
Verified
Journal Article
Open access
WCWilliam H. Cook
William H. Cook
CGConor S. Gillespie
Conor S. Gillespie
ABAli Bakhsh
Ali Bakhsh
AMAnthony G. Marson
Anthony G. Marson
MJMichael D. Jenkinson
Michael D. Jenkinson
AHAdel E. Helmy
Adel E. Helmy
Cranial meningioma are the most common type of primary brain tumor, and focal onset, tumor‐related seizures affect a significant proportion of patients. Seizures affect 30% of symptomatic preoperative patients and a further 12% of postoperative patients. Although most patients may be cured of their oncological disease by surgery, seizures confer disability, reduced quality‐of‐life, delayed return to driving and work, and increase the risk of sudden death. Tumor‐associated seizures are also more likely to be resistant to antiseizure medications (ASMs). ASMs are limited to treating the symptoms of epilepsy—seizures—but have no disease‐modifying effect on the mechanisms that cause or maintain seizure susceptibility. There is a need to be able to predict who is at risk of developing postoperative seizures for targeted prevention or closer monitoring of those at greater risk. Mechanisms underpinning brain tumor–related seizures are most likely multifactorial and related to morphological, biochemical, and metabolic causes. Brain tumors likely cause cortical hyperexcitability due to irritation caused by mass effect, brain invasion, and peritumoral brain edema. Inflammatory mediators are involved in epileptogenesis in animal models and human seizure syndromes and there are experimental data to support the development of inflammatory mediators as biomarkers for epileptogenesis. Meningioma‐associated seizures are incompletely understood and consequently unpredictable with current knowledge. In this review, we discuss the proposed mechanisms of epileptogenesis in brain tumors and putative neuroinflammatory mechanisms for meningioma‐associated seizures. Ultimately, we evaluate the potential of neuroinflammatory biomarkers of epileptogenesis in meningioma and the current challenges with extrapolating from current literature, which primarily consider epilepsy and intrinsic brain tumors. A prospective randomized controlled trial (STOP'EM: ISRCTN14381346) is open in the UK and will determine the role of two weeks of prophylactic levetiracetam in seizure‐naïve patients undergoing meningioma surgery and provide an opportunity to obtain serial blood measurements from patients to assist with biomarker discovery.

25 January 2022 in International Journal of Spine Surgery
Verified
Journal Article
Closed access
PDF file
WCWilliam H. Cook
William H. Cook
JBJoseph F. Baker
Joseph F. Baker
Background Most existing studies of lumbar anatomy do not consider ethnic influence and recruit mostly white participants. Recent studies have considered other populations; however, none have assessed Māori, the indigenous people of New Zealand (NZ). A computed tomography study of vertebral body (VB) and canal dimensions was performed for lumbar vertebrae of Māori and NZ European patients to evaluate for ethnic variation. Methods Lumbar vertebrae from 196 patients were measured using computed tomography. After interrater and intrarater reliability analyses, a single trained examiner measured VB heights, VB lengths, segmental angle, pedicle height and width, and vertebral canal length (VCL) and vertebral canal width for each level. Canal:body ratio was calculated. Demographic data recorded included age, sex, and ethnicity. Results VCL remained relatively constant through the lumbar spine; canal width increased to a maximum of 28.2 mm at L5. Canal:body ratios and pedicle height decreased while pedicle width increased to a maximum of 16.1 mm at L5. There were few differences between Māori and NZ Europeans except at the L5 level, where VCL and canal:body ratio were larger in NZ Europeans (P < 0.05), and pedicle height, width, and VB pediculolaminar length were larger in Māori (P < 0.05). Females had generally smaller measurements and age was a positive predictor of measured values (P < 0.05). Conclusions This study is the first to characterize lumbar anatomy in a Māori cohort. Adequately powered results demonstrated few differences between Māori and NZ Europeans. Isolated differences observed at L5 may be due to sacropelvic differences, which represent an area for further investigation. Level of Evidence 3. Clinical Relevance Diagnosis, surgical planning, ethnic differences.

16 March 2020 in Anz Journal of Surgery
Verified
Journal Article
Closed access
PDF file
WCWilliam H. Cook
William H. Cook
JBJoseph F. Baker
Joseph F. Baker